14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.500 $0.720 Thursday, 25th Apr 2024 ADXS stock ended at $0.550. This is 1.85% more than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 0% from a day low at $0.550 to a day high of $0.550.
90 days $0.500 $1.49
52 weeks $0.500 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
Sep 25, 2020 $0.352 $0.399 $0.340 $0.388 2 507 663
Sep 24, 2020 $0.479 $0.483 $0.355 $0.367 9 653 242
Sep 23, 2020 $0.421 $0.425 $0.382 $0.385 1 113 069
Sep 22, 2020 $0.420 $0.428 $0.413 $0.424 709 386
Sep 21, 2020 $0.440 $0.440 $0.402 $0.416 711 012
Sep 18, 2020 $0.431 $0.449 $0.430 $0.445 424 083
Sep 17, 2020 $0.450 $0.450 $0.421 $0.434 784 609
Sep 16, 2020 $0.447 $0.455 $0.440 $0.442 431 108
Sep 15, 2020 $0.457 $0.457 $0.437 $0.440 681 796
Sep 14, 2020 $0.440 $0.450 $0.435 $0.445 317 008
Sep 11, 2020 $0.439 $0.449 $0.436 $0.440 443 533
Sep 10, 2020 $0.438 $0.460 $0.420 $0.440 803 599
Sep 09, 2020 $0.454 $0.454 $0.400 $0.440 1 089 452
Sep 08, 2020 $0.433 $0.453 $0.421 $0.444 1 217 883
Sep 04, 2020 $0.440 $0.450 $0.425 $0.440 966 187
Sep 03, 2020 $0.440 $0.456 $0.420 $0.442 2 266 243
Sep 02, 2020 $0.470 $0.470 $0.432 $0.439 1 245 211
Sep 01, 2020 $0.480 $0.482 $0.448 $0.468 1 976 742
Aug 31, 2020 $0.525 $0.530 $0.480 $0.496 1 229 971
Aug 28, 2020 $0.484 $0.550 $0.484 $0.531 2 105 870
Aug 27, 2020 $0.455 $0.512 $0.453 $0.478 1 949 398
Aug 26, 2020 $0.470 $0.470 $0.450 $0.453 472 271
Aug 25, 2020 $0.450 $0.470 $0.450 $0.462 482 732
Aug 24, 2020 $0.470 $0.480 $0.432 $0.450 1 173 801
Aug 21, 2020 $0.479 $0.490 $0.461 $0.462 649 869
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT